Amedisys Net Worth 2010-2025 | AMED

Interactive chart of historical net worth (market cap) for Amedisys (AMED) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Amedisys net worth as of June 20, 2025 is $3.2B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.199B $2.348B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.031B 19.74
Encompass Health (EHC) United States $12.013B 25.47
DaVita (DVA) United States $10.339B 14.54
Chemed (CHE) United States $8.026B 25.23
Elanco Animal Health (ELAN) United States $6.685B 14.32
Option Care Health (OPCH) United States $5.163B 23.01
RadNet (RDNT) United States $4.144B 263.00
Addus HomeCare (ADUS) United States $2.094B 22.99
LifeStance Health (LFST) United States $1.878B 0.00
Astrana Health (ASTH) United States $1.345B 33.33
U.S Physical Therapy (USPH) United States $1.128B 29.13
Pennant (PNTG) United States $0.958B 35.17
Aveanna Healthcare Holdings (AVAH) United States $0.921B 52.44
Atai Life Sciences (ATAI) Germany $0.497B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.042B 0.00
Ontrak (OTRK) United States $0.006B 0.00
Psychemedics (PMD) United States $0.000B 0.00